Levothyroxine Sodium Products Enforcement of August 14, 2001 Compliance Date and Submission of New Applications
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 13, 2001
February 1, 2021
2d5e2030-11b1-4414-8987-9ca957a899b5
Related Documents
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies
Guidance DocumentDecember 11, 2001Center for Drug Evaluation and Research
Drug Products Containing Ensulizole, Hypromellose, Meradimate, Octinoxate, and Octisalate — Labeling Enforcement Policy
Guidance DocumentJune 3, 2003Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.